Study Of ATRN-119 In Patients With Advanced Solid Tumors
NCT04905914
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
132
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
ATRN-119
Sponsor
Aprea Therapeutics